Cosmos Health Q2 Revenue Climbs 29% to $19M, but Net Loss Doubles to $6.1M
COSM sits 35% above its 52-week low of $0.162.
Summary
Cosmos Health reported record Q2 revenue of $18.99M (up 29%) and improved adjusted gross margin, but net loss doubled to $6.09M due to non-cash fair-value charges. The company also updated its buyback progress to 5.11M shares repurchased for ~$1.11M.
Key Events · Earnings and Guidance · COSM
-
Record Q2 Revenue, Up 29%
Q2 2026 revenue reached $18.99M, up 28.8% from $14.75M in Q2 2025. H1 revenue was $36.91M, up 29.7% from $28.46M. Adjusted revenue was $19.32M for Q2, up 31.0%.
-
Net Loss Doubles to $6.09M
Q2 net loss was $6.09M vs $2.83M in Q2 2025, driven by $2.65M in non-cash charges, primarily fair-value adjustments on financing arrangements. H1 net loss was $8.89M vs $3.65M.
-
Adjusted Gross Margin Expands 165 bps
Adjusted gross profit rose 58.4% to $1.84M in Q2, with adjusted gross margin expanding to 9.54% from 7.89%. Adjusted EBITDA improved to -$1.13M from -$1.31M.
-
Balance Sheet Strengthens
Total liabilities decreased 13.3% to $40.79M from $47.05M at year-end 2025. Stockholders' equity rose 12.2% to $20.67M. Liquid assets totaled $4.15M.
Analysis · COSM · Trade & Services
Cosmos Health delivered record Q2 revenue of $18.99 million, up 28.8% year-over-year, with adjusted gross profit up 58% and adjusted gross margin expanding 165 basis points to 9.54%. However, the company's net loss more than doubled to $6.09 million from $2.83 million a year ago, driven by $2.65 million in non-cash charges, primarily fair-value adjustments on financing arrangements. The balance sheet strengthened with total liabilities down 13.3% to $40.79 million and stockholders' equity up 12.2% to $20.67 million. The company also updated its share repurchase program, having bought back 5.11 million shares for approximately $1.11 million as of the filing date. The mixed results — strong top-line growth and margin expansion offset by widening losses and ongoing going-concern doubts — make this a notable update for investors.
At the time of this filing, COSM was trading at $0.22 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $21.4M. The 52-week trading range was $0.16 to $1.32. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.